IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v21y2020i1d10.1007_s10198-019-01115-5.html
   My bibliography  Save this article

Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study

Author

Listed:
  • Yuliya Chuvarayan

    (University of Wuppertal)

  • Robert P. Finger

    (University of Bonn)

  • Juliane Köberlein-Neu

    (University of Wuppertal)

Abstract

Background Visual impairment and blindness cause a considerable and increasing economic burden affecting not only persons with vision loss and their families, but also societies. For the majority of countries, there is no solid database that would allow a comprehensive assessment of costs from a societal perspective. The present study was conducted to fill this gap. Objectives To investigate resource utilization of blind or visually impaired people and to assess the economic burden of blindness and visual impairment in Germany. Methods This cross-sectional cost-of-illness study measures the economic burden of blindness and visual impairment bottom-up and from a societal perspective. Therefore, blind and visually impaired persons were recruited via national self-help organizations (prevalence-based approach) and interviewed regarding their utilized resources using various survey modes (mixed-mode approach). The observation period was 6 months retrospectively. Utilized resources were valued applying standardized unit costs (macro-costing). Calculations for the study population provided direct and indirect costs per person for a period of 6 months. Further cost per category was extrapolated to 1 year for the general population of Germany. Uncertainty of results was addressed applying univariate deterministic sensitivity analyses. Results Complete data were collected from 683 participants (54.84% women; average age: 60.28 ± 17.02 years). Decreasing vision was associated with increasing costs (p

Suggested Citation

  • Yuliya Chuvarayan & Robert P. Finger & Juliane Köberlein-Neu, 2020. "Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 115-127, February.
    • Handle: RePEc:spr:eujhec:v:21:y:2020:i:1:d:10.1007_s10198-019-01115-5
    DOI: 10.1007/s10198-019-01115-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10198-019-01115-5
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s10198-019-01115-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Bjoern Schwander, 2014. "Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany," Health Economics Review, Springer, vol. 4(1), pages 1-10, December.
    2. Antoine Lafuma & Antoine Brezin & Francis Fagnani & Viviane Mimaud & Mounir Mesbah & Gilles Berdeaux, 2006. "Nonmedical economic consequences attributable to visual impairment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(3), pages 158-164, September.
    3. Alan Cruess & Gergana Zlateva & Xiao Xu & Gièle Soubrane & Daniel Pauleikhoff & Andrew Lotery & Jordi Mones & Ronald Buggage & Caroline Schaefer & Tyler Knight & Thomas Goss, 2008. "Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration," PharmacoEconomics, Springer, vol. 26(1), pages 57-73, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Sweta Sneha & Avijit Singh & Anshu Singh & Madhu Bhadauria & Christopher Burgess & Lisero Mugula, 2022. "Teleophthalmology: A Case of Eye Care Delivery," International Journal of E-Adoption (IJEA), IGI Global, vol. 15(2), pages 1-17, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Bjoern Schwander, 2014. "Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany," Health Economics Review, Springer, vol. 4(1), pages 1-10, December.
    2. Kathleen Ke, 2010. "The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(6), pages 525-531, December.
    3. Irina Odnoletkova & Dirk Ramaekers & Frank Nobels & Geert Goderis & Bert Aertgeerts & Lieven Annemans, 2016. "Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-18, October.
    4. Fasterholdt, Iben & Krahn, Murray & Kidholm, Kristian & Yderstræde, Knud Bonnet & Pedersen, Kjeld Møller, 2017. "Review of early assessment models of innovative medical technologies," Health Policy, Elsevier, vol. 121(8), pages 870-879.
    5. Alberto Ferreira & Alexandros Sagkriotis & Melvin Olson & Jingsong Lu & Charles Makin & Fran Milnes, 2015. "Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA," PLOS ONE, Public Library of Science, vol. 10(7), pages 1-12, July.
    6. Bennion, Amy E. & Shaw, Rachel L. & Gibson, Jonathan M., 2012. "What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research," Social Science & Medicine, Elsevier, vol. 75(6), pages 976-985.
    7. Paul Mitchell & Lieven Annemans & Richard White & Meghan Gallagher & Simu Thomas, 2011. "Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration," PharmacoEconomics, Springer, vol. 29(2), pages 107-131, February.
    8. Ra Ho & Lina D Song & Jin A Choi & Donghyun Jee, 2018. "The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-14, October.

    More about this item

    Keywords

    Blindness; Visual impairment; Costs; Cost of illness; Societal perspective;
    All these keywords.

    JEL classification:

    • I19 - Health, Education, and Welfare - - Health - - - Other

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:21:y:2020:i:1:d:10.1007_s10198-019-01115-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.